A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx,
A pioneer of intensity-modulated radiation therapy (IMRT), Nomos of Sewickley, PA, has launched a remote treatment planning service that promises to provide treatment facilities more rapid access to this type of radiation therapy. The product, Nomos Rx, is aimed at treatment facilities that might not be able to implement a quality IMRT program due to the cost of resources and equipment required. IMRT allows the delivery of increased radiation doses to tumor while limiting the impact on surrounding healthy tissue.
Additionally, the privately held company has struck an agreement to partner with MCP International, a remarketer of radiation therapy equipment, to provide an IMRT package that includes a linear accelerator, multileaf collimator, CT scanner, and inverse treatment planning software. Nomos Peacock System will be coupled with MCP's refurbished digital linear accelerator and spiral CT scanning equipment to provide a turnkey integrated equipment package available for less than the cost of a new IMRT-capable linear accelerator.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.